Free trial units of all ARISTADA® (aripiprazole lauroxil) doses, including ARISTADA INITIO™ (aripiprazole lauroxil) and the first and only 2-month dose (ARISTADA 1064 mg) for schizophrenia, are available for hospitalized patients.
ARISTADA and ARISTADA INITIO are provided free of charge at eligible hospitals for appropriate patients. Hospitalized patients may receive up to 2 free trial units of ARISTADA per calendar year, subject to quantity limits. ARISTADA INITIO will be offered and available to ship with each ARISTADA dose. It is important to note that medication errors, including substitution and dispensing errors, between ARISTADA INITIO and ARISTADA could occur. ARISTADA INITIO is intended for single administration only. Do not substitute ARISTADA INITIO for ARISTADA because of differing pharmacokinetic profiles.
Orders ship directly to your hospital.* No requirement for subsequent use of ARISTADA for any patient receiving free trial units through this program.
*Shipments will not be processed on holidays or pending inclement weather. These factors may result in a delay in shipment.
Additional limits may apply per institution. This program, as amended from time to time, will be available through December 31, 2019.†
†Alkermes, Inc. may terminate the program prior to December 31, 2019, upon 60 days’ notice to all participating inpatient pharmacies, or upon less or no notice if there is a change in interpretation of federal or state laws supporting the continuation of this program.
For patients transitioning from hospital to outpatient care, be sure to select the Transition of Care Support Program on the enrollment form. A prescription is not required for transition support. Through the program, ARISTADA Care Support nurse coordinators can: